Dearborn Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.74M | Sell |
69,875
-2,695
| -4% | -$377K | 0.53% | 58 |
|
|
2025
Q4 | $8.91M | Sell |
72,570
-3,283
| -4% | -$399K | 0.44% | 60 |
|
|
2025
Q3 | $8.42M | Sell |
75,853
-1,707
| -2% | -$194K | 0.39% | 61 |
|
|
2025
Q2 | $8.6M | Buy |
77,560
+1,065
| +1% | +$113K | 0.41% | 60 |
|
|
2025
Q1 | $8.57M | Sell |
76,495
-13,906
| -15% | -$1.43M | 0.41% | 65 |
|
|
2024
Q4 | $8.35M | Sell |
90,401
-228,724
| -72% | -$20.6M | 0.35% | 67 |
|
|
2024
Q3 | $26.8M | Sell |
319,125
-11,954
| -4% | -$912K | 1.09% | 44 |
|
|
2024
Q2 | $22.7M | Sell |
331,079
-3,282
| -1% | -$219K | 0.98% | 47 |
|
|
2024
Q1 | $24.5M | Sell |
334,361
-102,882
| -24% | -$7.91M | 1.05% | 47 |
|
|
2023
Q4 | $35.4M | Sell |
437,243
-11,657
| -3% | -$907K | 1.29% | 40 |
|
|
2023
Q3 | $33.6M | Buy |
448,900
+4,498
| +1% | +$346K | 1.32% | 38 |
|
|
2023
Q2 | $34.3M | Sell |
444,402
-7,399
| -2% | -$590K | 1.31% | 38 |
|
|
2023
Q1 | $37.5M | Sell |
451,801
-700
| -0.2% | -$58K | 1.47% | 27 |
|
|
2022
Q4 | $38.8M | Sell |
452,501
-1,846
| -0.4% | -$146K | 1.57% | 25 |
|
|
2022
Q3 | $28M | Buy |
454,347
+12
| +0% | +$757 | 1.24% | 42 |
|
|
2022
Q2 | $28.1M | Buy |
454,335
+3,484
| +0.8% | +$216K | 1.19% | 46 |
|
|
2022
Q1 | $26.8M | Buy |
450,851
+11,611
| +3% | +$742K | 1.02% | 49 |
|
|
2021
Q4 | $31.9M | Sell |
439,240
-1,623
| -0.4% | -$112K | 1.16% | 43 |
|
|
2021
Q3 | $30.8M | Buy |
440,863
+2,067
| +0.5% | +$145K | 1.25% | 44 |
|
|
2021
Q2 | $30.2M | Buy |
438,796
+2,343
| +0.5% | +$156K | 1.22% | 44 |
|
|
2021
Q1 | $28.2M | Buy |
436,453
+22,217
| +5% | +$1.43M | 1.2% | 44 |
|
|
2020
Q4 | $24.1M | Buy |
414,236
+3,065
| +0.7% | +$185K | 1.1% | 46 |
|
|
2020
Q3 | $26M | Sell |
411,171
-421
| -0.1% | -$29.2K | 1.29% | 38 |
|
|
2020
Q2 | $31.7M | Buy |
411,592
+58,904
| +17% | +$4.51M | 1.71% | 22 |
|
|
2020
Q1 | $26.4M | Buy |
352,688
+9,538
| +3% | +$659K | 1.64% | 24 |
|
|
2019
Q4 | $22.3M | Buy |
343,150
+27,363
| +9% | +$1.78M | 1.14% | 46 |
|
|
2019
Q3 | $20M | Buy |
315,787
+29,926
| +10% | +$1.96M | 1.16% | 46 |
|
|
2019
Q2 | $19.3M | Buy |
285,861
+10,294
| +4% | +$677K | 1.18% | 45 |
|
|
2019
Q1 | $17.9M | Buy |
275,567
+16,984
| +7% | +$1.13M | 1.2% | 44 |
|
|
2018
Q4 | $16.2M | Sell |
258,583
-623
| -0.2% | -$43.5K | 1.25% | 39 |
|
|
2018
Q3 | $20M | Buy |
259,206
+71,145
| +38% | +$5.37M | 1.4% | 34 |
|
|
2018
Q2 | $13.3M | Sell |
188,061
-5,052
| -3% | -$357K | 1.04% | 44 |
|
|
2018
Q1 | $14.6M | Sell |
193,113
-4,715
| -2% | -$375K | 1.12% | 44 |
|
|
2017
Q4 | $14.2M | Sell |
197,828
-7,078
| -3% | -$538K | 1.02% | 47 |
|
|
2017
Q3 | $16.6M | Sell |
204,906
-12,321
| -6% | -$942K | 1.22% | 40 |
|
|
2017
Q2 | $15.4M | Buy |
217,227
+4,485
| +2% | +$298K | 1.14% | 42 |
|
|
2017
Q1 | $14.4M | Buy |
212,742
+8,214
| +4% | +$578K | 1.12% | 41 |
|
|
2016
Q4 | $14.6M | Buy |
204,528
+3,088
| +2% | +$230K | 1.22% | 38 |
|
|
2016
Q3 | $15.9M | Buy |
201,440
+2,779
| +1% | +$226K | 1.34% | 33 |
|
|
2016
Q2 | $16.6M | Buy |
198,661
+15,761
| +9% | +$1.4M | 1.44% | 28 |
|
|
2016
Q1 | $16.8M | Buy |
182,900
+9,120
| +5% | +$822K | 1.56% | 26 |
|
|
2015
Q4 | $17.6M | Buy |
173,780
+81,664
| +89% | +$8.5M | 1.64% | 15 |
|
|
2015
Q3 | $9.04M | Sell |
92,116
-2,547
| -3% | -$283K | 0.91% | 47 |
|
|
2015
Q2 | $11.1M | Sell |
94,663
-14,210
| -13% | -$1.55M | 1.07% | 35 |
|
|
2015
Q1 | $10.7M | Buy |
108,873
+35,222
| +48% | +$3.58M | 0.93% | 40 |
|
|
2014
Q4 | $6.94M | Sell |
73,651
-3,236
| -4% | -$335K | 0.64% | 57 |
|
|
2014
Q3 | $8.18M | Sell |
76,887
-6,347
| -8% | -$621K | 0.79% | 46 |
|
|
2014
Q2 | $6.9M | Buy |
83,234
+363
| +0.4% | +$28.3K | 0.68% | 52 |
|
|
2014
Q1 | $5.87M | Sell |
82,871
-5,374
| -6% | -$421K | 0.64% | 56 |
|
|
2013
Q4 | $6.63M | Sell |
88,245
-5,807
| -6% | -$404K | 0.77% | 41 |
|
|
2013
Q3 | $5.91M | Buy |
94,052
+375
| +0.4% | +$22.4K | 0.78% | 41 |
|
|
2013
Q2 | $4.8M | Buy |
+93,677
| New | +$4.88M | 0.68% | 43 |
|
Other funds holding GILD
VCM
VPM
Dearborn Partners's GILD Position: Q1 2026 in Review
Dearborn Partners reduced its Gilead Sciences (GILD) stake by 3.7% in Q1 2026, selling an estimated $377K and leaving 69,875 shares worth $9.74M. The position accounts for 0.53% of the portfolio, ranked #58.
Dearborn Partners first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Dearborn Partners held 69,875 shares of Gilead Sciences worth $9.74M as of Q1 2026.
- Dearborn Partners sold 2,695 Gilead Sciences shares in Q1 2026, an estimated $377K.
- Gilead Sciences made up 0.53% of Dearborn Partners's portfolio in Q1 2026, its #58 holding.
- Dearborn Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Dearborn Partners's Gilead Sciences position peaked at $38.8M in Q4 2022.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.